Prevalence of Respiratory Symptoms and Diseases Associated with Gastroesophageal Reflux DiseaseRóka R.a · Rosztóczy A.a · Izbéki F.a · Taybani Z.b · Kiss I.c · Lonovics J.a · Wittmann T.a
aFirst Department of Medicine and bDepartment of Radiology, University of Szeged, Szeged, and cSecond Department of Internal Medicine, ‘Réthy Pál’ Hospital, Békéscsaba, Hungary
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Aim: Investigation of the prevalence of respiratory symptoms and diseases associated with gastroesophageal reflux disease (GERD). Patients and Methods: 299 subjects with GERD were submitted to upper gastrointestinal endoscopy and 24-hour esophageal pH monitoring and a symptom analysis. Results: Chronic respiratory symptoms or diseases were present in 18% (56/299). Chronic cough was observed in 42/56 patients, while typical reflux symptoms such as heartburn and acid regurgitation were observed in 30/56 and 24/56 cases, respectively. The prevalence of airway diseases was chronic bronchitis 12/56, asthma 10/56, recurrent pneumonia 10/56, chronic sinusitis 7/56 and chronic laryngitis 1/56. In patients with respiratory complications pathologic acid reflux was established in 29/51 cases on the basis of the DeMeester score, while 17/51 had pathologic postprandial, nocturnal or diurnal reflux events. Upper gastrointestinal endoscopy revealed a normal esophageal mucosa in 6/56, Savary-Miller stage I esophagitis in 23/56, stage II in 15/56, stage III in 5/56 and stage IV in 6/56 patients. Conclusions: These investigations have demonstrated an abnormal 24-hour pH score in about half of the patients with GERD-associated respiratory complications, and indicated that short reflux events are characteristic of the reflux activity in one third of this population.
© 2005 S. Karger AG, Basel
- Deschner WK, Benjamin SB: Extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 1989;84:1–5.
- Hogan WJ: Spectrum of supraesophageal complications of gastroesophageal reflux disease. Am J Med 1997;103:77S–83S.
- Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G: Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1804–1808.
- Gastal OL, Castell JA, Castell DO: Frequency and site of gastroesophageal reflux in patients with chest symptoms. Chest 1994;106:1793–1796.
- Harding SM, Guzzo MR, Richter JE: 24-h esophageal pH testing in asthmatics. Chest 1999;115: 654–659.
- Palombini BC, Villanova CA, Araujo E, Gastal OL, Alt DC, Stolz DP, Palombini CO: A pathogenic triad in chronic cough. Chest 1999;116:279–284.
- Schnatz PF, Castell JA, Castell DO: Pulmonary symptoms associated with gastroesophageal reflux: Use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol 1996;91:1715–1719.
- Sontag SJ, O’Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R: Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990;99:613–620.
- El-Serag HB, Sonnenberg A: Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997;113:755–760.
- Gislason T, Janson C, Vermeire P, Plaschke P, Bjornsson E, Gislason D, Boman G: Respiratory symptoms and nocturnal gastroesophageal reflux: A population-based study of young adults in three European countries. Chest 2002;121:158–163.
- Harding SM: Gastroesophageal reflux, asthma, and mechanisms of interaction. Am J Med 2001;111:8S–12S.
- Ward BW, Wu WC, Richter JE, Hackshaw BT, Castell DO: Long-term follow-up of symptomatic status of patients with noncardiac chest pain: Is diagnosis of esophageal etiology helpful? Am J Gastroenterol 1987;82:215–218.
Savary M, Miller G: L’oesophage. Manuel et atlas d’endoscopie. Solothurn, Gassamann, 1977.
DeMeester TR, Johnson LF, Joseph GJ: Patterns of gastroesophageal reflux in health and disease. Am Surg 1976;184:459–469.
- Mason RJ, Öberg S, Cedric G, Bremner CG, Peters JH, Gadenstätter M, Ritter M, DeMeester TR: Postprandial gastroesophageal reflux in normal volunteers and symptomatic patients. J Gastrointest Surg 1998;2:342–349.
Dalton CB: The esophageal motility laboratory. Materials and equipment; in Castell DO (ed): Esophageal Motility Testing. New York, Elsevier, 1987, pp 28–78.
- Rosztoczy A, Kovacs L, Wittmann T, Lonovics J, Pokorny G: Manometric assessment of impaired esophageal motor function in primary Sjögren’s syndrome. Clin Exp Rheumatol 2001;19:147–152.
- Richter JE, Blackwell JN, Wu WC: Esophageal manometry in 95 healthy adult volunteers. Dig Dis Sci 1987;32:583–592.
- Kahrilas PJ: Esophageal motor activity and acid clearance. Gastroenterol Clin North Am 1990;19:537–550.
Kiss I, Rosztóczy A, Wittmann T, et al: New radiologic method for evaluation of motility disorders in gastroesophageal reflux disease (GERD). Z Gastroenterol 1994;32:A77.
- Sontag SJ, Schnell TG, Miller TQ, Khandelwal S, O’Connell S, Chejfec G, Greenlee H, Seidel UJ, Brand L: Prevalence of oesophagitis in asthmatics. Gut 1992;33:872–876.
- Field SK, Underwood M, Brant R, Cowie RL: Prevalence of gastroesophageal reflux symptoms in asthma. Chest 1996;109:316–322.
- Groen JN, Smout AJPM: Suproesophageal manifestations of gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2003;15:1339–1350.
- Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, Vieth M, Willich SN, Lindner D, Stolte M, Malfertheiner P: Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: An analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003;17:1515–1520.
- Richter JE: Extraesophageal presentations of gastroesophageal reflux disease: An overview. Am J Gastroenterol 2000;95:S1–S3.
- Irwin RS, French CL, Curley FJ, Zawacki JK, Bennett FM: Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 1993;104:1511–1517.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.